Frontline plc/ CY0200352116 /
| 2024-05-31 1:12:19 PM | Chg. +8.10 | Volume | Bid4:30:00 PM | Ask4:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 306.00NOK | +2.72% | 708 Turnover: 212,124.40 |
-Bid Size: - | -Ask Size: - | 67.11 bill.NOK | - | - |
GlobeNewswire
05-31
Verizon Business brings the Verizon Business Innovation Sessions to New York City
GlobeNewswire
05-31
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
05-31
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clon...
GlobeNewswire
05-28
Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hosp...
GlobeNewswire
05-27
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
GlobeNewswire
05-24
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
GlobeNewswire
05-23
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire
05-23
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
05-21
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Ph...
GlobeNewswire
05-20
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
GlobeNewswire
05-20
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for it...
GlobeNewswire
05-16
Harri Announces Product Innovation Designed to Propel the Frontline Employee Experience and Restaura...
GlobeNewswire
05-16
Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million
